Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


Glucose levels and risk of dementia.

Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB.

N Engl J Med. 2013 Aug 8;369(6):540-8. doi: 10.1056/NEJMoa1215740. Erratum in: N Engl J Med. 2013 Oct 10;369(15):1476.


Normal fasting plasma glucose levels and type 2 diabetes in young men.

Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A; Israeli Diabetes Research Group..

N Engl J Med. 2005 Oct 6;353(14):1454-62. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2401.


Fasting serum glucose level and cancer risk in Korean men and women.

Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM.

JAMA. 2005 Jan 12;293(2):194-202.


[Are high glucose levels a risk factor for dementia? High blood glucose levels increase the risk of dementia--not only in diabetes].

Müssig K.

Dtsch Med Wochenschr. 2013 Oct;138(43):2184. doi: 10.1055/s-0032-1329063. Epub 2013 Oct 16. German. No abstract available.


Association Between Random Measured Glucose Levels in Middle and Old Age and Risk of Dementia-Related Death.

Rosness TA, Engedal K, Bjertness E, Strand BH.

J Am Geriatr Soc. 2016 Jan;64(1):156-61. doi: 10.1111/jgs.13870.


Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Emerging Risk Factors Collaboration., Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J.

N Engl J Med. 2011 Mar 3;364(9):829-41. doi: 10.1056/NEJMoa1008862. Erratum in: N Engl J Med. 2011 Mar 31;364(13):1281.


Hyperglycemia and adverse pregnancy outcomes.

HAPO Study Cooperative Research Group., Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA.

N Engl J Med. 2008 May 8;358(19):1991-2002. doi: 10.1056/NEJMoa0707943.


Diabetes and cardiovascular events in hypertensive patients.

Alderman MH, Cohen H, Madhavan S.

Hypertension. 1999 May;33(5):1130-4.


Glucose levels and risk of dementia.

Kielstein JT.

N Engl J Med. 2013 Nov 7;369(19):1863. doi: 10.1056/NEJMc1311765#SA1. No abstract available.


Glucose levels and risk of dementia.

Crane PK, Walker R, Larson EB.

N Engl J Med. 2013 Nov 7;369(19):1863-4. doi: 10.1056/NEJMc1311765. No abstract available.


Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ.

Arch Neurol. 2012 May;69(5):594-600.


Fresh Fruit Consumption and Major Cardiovascular Disease in China.

Du H, Li L, Bennett D, Guo Y, Key TJ, Bian Z, Sherliker P, Gao H, Chen Y, Yang L, Chen J, Wang S, Du R, Su H, Collins R, Peto R, Chen Z; China Kadoorie Biobank Study..

N Engl J Med. 2016 Apr 7;374(14):1332-43. doi: 10.1056/NEJMoa1501451.


Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators., Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.


Raised blood glucose as a predictor of dementia risk in adults with and without diabetes.

Riby LM, Riby DM.

Evid Based Med. 2014 Jun;19(3):112. doi: 10.1136/eb-2013-101557. Epub 2013 Dec 12. No abstract available.


Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

AIM-HIGH Investigators., Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W.

N Engl J Med. 2011 Dec 15;365(24):2255-67. doi: 10.1056/NEJMoa1107579. Epub 2011 Nov 15. Erratum in: N Engl J Med. 2012 Jul 12;367(2):189.


Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.

Sarwar N, Aspelund T, Eiriksdottir G, Gobin R, Seshasai SR, Forouhi NG, Sigurdsson G, Danesh J, Gudnason V.

PLoS Med. 2010 May 25;7(5):e1000278. doi: 10.1371/journal.pmed.1000278. Review.


An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study.

Gao L, Matthews FE, Sargeant LA, Brayne C; MRC CFAS..

BMC Public Health. 2008 Feb 11;8:54. doi: 10.1186/1471-2458-8-54.


Effect of ramipril on the incidence of diabetes.

DREAM Trial Investigators., Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR.

N Engl J Med. 2006 Oct 12;355(15):1551-62. Epub 2006 Sep 15.


Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000.

Imperatore G, Cadwell BL, Geiss L, Saadinne JB, Williams DE, Ford ES, Thompson TJ, Narayan KM, Gregg EW.

Am J Epidemiol. 2004 Sep 15;160(6):531-9.


Excess Mortality among Persons with Type 2 Diabetes.

Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M.

N Engl J Med. 2015 Oct 29;373(18):1720-32. doi: 10.1056/NEJMoa1504347.

Supplemental Content

Support Center